Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
D000433:1-Propanol / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000032:analysis; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000328:Adult; D000605:Amino Alcohols / Q000494:pharmacology; D003408:Cresols / Q000494:pharmacology; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005994:Glycerophosphates / Q000032:analysis; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D008297:Male; D009578:Nitrobenzenes / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects*; D010627:Phenethylamines / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D013015:Sotalol / Q000494:pharmacology; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003408:Cresols; D005994:Glycerophosphates; D006454:Hemoglobins; D009578:Nitrobenzenes; D010627:Phenethylamines; D010636:Phenols; D011437:Propylamines; D000255:Adenosine Triphosphate; D000433:1-Propanol; D011433:Propranolol; D013015:Sotalol